Podcast:Considerations in ophthalmic formulation development for various ocular diseases
Considerations in Ophthalmic Formulation Development for Various Ocular Diseases
Sponsored By
For more than 10 years, Dow has been intimately involved in ophthalmic formulation development for various ocular diseases such as cataract, ocular hyphema, dry-eye, age-related macular degeneration, glaucoma, etc. This podcast will attempt to share such ophthalmic formulation technology with the scientists and formulators who are interested in developing eye-care products.
WHITEPAPERS
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
